Clinical Trial Update: Safety and Effectiveness of Collagen Cross Linking in Progressive Mild and Moderate Keratoconus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and effectiveness of Collagen Cross Linking for progressive mild to moderate keratoconus; current status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Degeneration
• Keratoconus

Drugs mentioned

• Collagen Cross-Linking (riboflavin and UV-A irradiation) (Riboflavin with ultraviolet A irradiation)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Cornea Degeneration, Progressive Keratoconus | Phase 3 | Status: UNKNOWN